Early and Sustained Treatment Satisfaction Observed in Patients With Moderate to Severe Psoriasis Treated With Ixekizumab: Results From Second Interim Analysis of the Real-World Psoriasis in Special Areas (PSoSA) Study. J of Skin [Internet]. 2025 Jan. 13 [cited 2025 Apr. 13];9(1):s509. Available from: https://skin.dermsquared.com/skin/article/view/3154